Natalie Mount

Selectivity of sildenafil and other phosphodiesterase type 5 (PDE5) inhibitors against all human phosphodiesterase families

Eugene Gbekor, Sue Betheil, Lindsay Fawcett et al. · European Urology Supplements · 2002 · 45 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Discovery of a Selective Small-Molecule Melanocortin-4 Receptor Agonist with Efficacy in a Pilot Study of Sexual Dysfunction in Humans

Mark I. Lansdell, David Hepworth, Andrew Calabrese et al. · Journal of Medicinal Chemistry · 2010 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

A Novel Series of Potent and Selective PDE5 Inhibitors with Potential for High and Dose-Independent Oral Bioavailability

Charlotte Allerton, Chris Barber, Kevin Beaumont et al. · Journal of Medicinal Chemistry · 2006 · 29 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Proceedings: International Regulatory Considerations on Development Pathways for Cell Therapies

Ellen G. Feigal, Katherine Tsokas, Sowmya Viswanathan et al. · Stem Cells Translational Medicine · 2014 · 25 citations · Full text

Pharmacy, Cell Biology, Regulatory Policy +17

Preclinical and Clinical Pharmacokinetics of PF-02413873, a Nonsteroidal Progesterone Receptor Antagonist

Peter J. Bungay, Sarah Tweedy, David Howe et al. · Drug Metabolism and Disposition · 2011 · 21 citations

Medicine, Pharmacokinetics, Pharmacology +13